Blackrock, INC Schedule 13G passive stakes
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting an 8.0% beneficial ownership stake in Assurant, Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.1% Passive Stake in Atea Pharmaceuticals
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.1% beneficial ownership stake in Atea Pharmaceuticals, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 9.95% beneficial ownership stake in Atlantic Union Bankshares Corp as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 4 to Schedule 13G, revealing a beneficial ownership of 15.9% of Avista Corp's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 6.7% of Credo Technology Group Holding Ltd's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 3 to its Schedule 13G, reporting a 7.6% beneficial ownership stake in Patria Investments Limited as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 3 to its Schedule 13G, reporting a beneficial ownership of 8.5% in StoneCo Ltd.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.6% Stake in XP Inc. Class A Stock
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 6.6% of XP Inc.'s Class A Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 4 to its Schedule 13G, disclosing a passive beneficial ownership of 8.1% in Genco Shipping & Trading Ltd.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.8% Passive Stake in Coca-Cola FEMSA
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.8% passive beneficial ownership stake in Coca-Cola FEMSA SAB de CV as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.5% Stake in CEMEX SAB DE CV Common Stock
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 8.5% of CEMEX SAB DE CV's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.2% beneficial ownership stake in STMicroelectronics N.V. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 9 to its Schedule 13G, reporting a 6.7% beneficial ownership stake in ASML Holding NV as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 3 to Schedule 13G, reporting a 7.9% beneficial ownership stake in CNH Industrial N.V. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.1% passive beneficial ownership stake in Seagate Technology Holdings Public Limited Company as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 12 to its Schedule 13G, disclosing a 9.0% beneficial ownership stake in Pentair plc as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 6.9% of Medtronic plc's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 10 to Schedule 13G, reporting a 6.7% beneficial ownership stake in Johnson Controls International PLC as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant 8.7% Stake in WPP PLC
BlackRock, Inc. has filed an updated Schedule 13G, disclosing its continued beneficial ownership of 8.7% of WPP PLC's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 5 to its Schedule 13G, disclosing a 7.2% beneficial ownership stake in Amcor PLC as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.3% Passive Stake in NovoCure Ltd
Investment giant BlackRock, Inc. has reported a passive beneficial ownership of 8.3% in NovoCure Ltd's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.2% Passive Stake in Nomura Holdings Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.2% beneficial ownership stake in Nomura Holdings Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Updates Significant Passive Stake in Ambarella, Holding 7.3% of Common Stock
BlackRock, Inc. has filed an Amendment No. 6 to its Schedule 13G, disclosing a 7.3% beneficial ownership stake in Ambarella, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing its beneficial ownership of 7.3% of the common stock of FTAI Aviation Ltd. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing an increased beneficial ownership of 7.1% in Rio Tinto PLC's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed Amendment No. 4 to its Schedule 13G, disclosing a 7.6% beneficial ownership stake in BP PLC as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 11 to its Schedule 13G, reporting a beneficial ownership of 7.3% of Smith & Nephew PLC's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.6% Passive Stake in AstraZeneca PLC
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.6% beneficial ownership stake in AstraZeneca PLC as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.2% Passive Stake in TE Connectivity PLC
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.2% passive beneficial ownership stake in TE Connectivity PLC as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 15.1% Stake in Adient plc, Maintaining Significant Beneficial Ownership
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 15.1% beneficial ownership stake in Adient plc as of March 31, 2025, through various subsidiaries and managed funds.